抗肽基精氨酸脫亞氨酶Ⅳ(PADI4)單克隆抗體
Anti-Peptidyl Arginine Deiminase Type IV (PADI4) Monoclonal Antibody
PAD; PADI5; PDI4; PDI5; Peptidyl Arginine Deiminase Type V; Peptidylarginine deiminase IV
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
Human Jurkat cell line was fixed with 2% paraformaldehyde (10 min) , permeabilised with 0.1% BSA-Triton X-100,then stained with 10μg/ml mouse Anti-human PADI4 Monoclonal Antibody (Catalog FAF709Hu02, red histogram) or Isotype control antibody (Catalog IS067-Mu03, green histogram), followed by 1μg/ml FITC-conjugated Anti-mouse IgG Secondary Antibody (Catalog SAA544Mu18).
通過ISO 9001、ISO 13485質(zhì)量體系認證
用法
Flow cytometry: 10μg/ml;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過一年。避免反復凍融。
贈品
增值服務
相關產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應用(僅供研究使用，不用于臨床診斷！) |
| APF709Hu01 | 肽基精氨酸脫亞氨酶Ⅳ(PADI4)活性蛋白 | Cell?culture;?Activity?Assays. |
| RPF709Hu01 | 肽基精氨酸脫亞氨酶Ⅳ(PADI4)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAF709Hu01 | 肽基精氨酸脫亞氨酶Ⅳ(PADI4)多克隆抗體 | IHC |
| MAF709Hu21 | 肽基精氨酸脫亞氨酶Ⅳ(PADI4)單克隆抗體 | WB |
| MAF709Hu22 | 肽基精氨酸脫亞氨酶Ⅳ(PADI4)單克隆抗體 | WB |
| MAF709Hu23 | 肽基精氨酸脫亞氨酶Ⅳ(PADI4)單克隆抗體 | WB |
| MAF709Hu24 | 肽基精氨酸脫亞氨酶Ⅳ(PADI4)單克隆抗體 | WB |
| FAF709Hu02 | 抗肽基精氨酸脫亞氨酶Ⅳ(PADI4)單克隆抗體 | FCM |
| SEF709Hu | 肽基精氨酸脫亞氨酶Ⅳ(PADI4)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMF709Hu | 肽基精氨酸脫亞氨酶Ⅳ(PADI4)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| Arthritis Res Ther. | Enhanced neutrophil extracellular trap generation in rheumatoid arthritis: analysis of underlying signal transduction pathways and potential diagnostic utility[Pubmed:Pmc4229860] |
| Journal of Molecular?Cell?Biology | Peptidylarginine deiminase 4 concentration, but not polymorphisms, is associated with ICU mortality in septic shock patients[Pubmed:30044533] |
| Journal of Inflammation Research | Release of active peptidylarginine deiminase into the circulation during acute inflammation induced by coronary artery bypass surgery[Pubmed: 31213874] |
| Revista da Associacao Medica Brasileira | Evaluation of peptidylarginine deiminase 4 and PADI4 polymorphisms in sepsis-induced acute kidney injury[] |